Serum, Bharat Biotech jointly pledge for smooth vaccine roll out

New Delhi: Serum Institute and Bharat Biotech on Tuesday issued a joint statement pledging to provide their Covid-19 vaccines to India and globally.

"Adar Poonawala and Krishna Ella, jointly on behalf of the two companies, today communicated their combined intent to develop, manufacture and supply the Covid-19 vaccines for India and globally," the statement read.

It went on to highlight the importance of vaccines as a global public health good that have "the power to save lives and accelerate the return to economic normalcy at the earliest."


Bharat Biotech's chairman Krishna Ella had earlier on Monday retaliated to Serum CEO Adar Poonawalla's statement of vaccines except Pfizer, Moderna and Oxford-AstraZeneca being "safe like water".

“We do 200% honest clinical trials and yet we receive backlash. If I am wrong, tell me. Some companies have branded me (our vaccine) like 'water'. I want to deny that. We are scientists," Ella said.


Poonawalla had earlier said that Covishield’s emergency use approval was granted on the condition that the company does not export the shots to ensure enough stockpile for India.

Covishield and Bharat Biotech’s Covaxin have both got emergency use approval in India as of this week.